REGN

STRONG BUY

Regeneron Pharmaceuticals, Inc.

Healthcare · Rank #5 · Analyzed Jul 13, 2026

$664.52

Current Price

$1215.76

Intrinsic Value

+83.0%

Upside/Downside

9.8/10

Score

4/5

Quality

Analysis Summary

Valuation Consensus2/3 methods agree

Quality Score4/5.0

Framework RatingSTRONG BUY

Price vs Intrinsic ValueUndervalued by 83.0%

Fair Value Range

Low$232.96

Base (IV)$1215.76

High$1492.65

Entry Points

Conservative$163.07

Moderate$232.96

Aggressive$851.03

Quality & Moat Breakdown

Return on Equity14.5% → 0.5/1.0

Debt LevelD/E 9 → 1.0/1.0

Revenue QualityGrowth 6.6%, margin Δ-38.0% +recovery → 1.0/1.0

Moat Strength2.5/5 → 0.5/1.0

Profit Margins29.6% → 1.0/1.0

Methodology

This analysis uses a unified valuation framework combining three methods, Discounted Cash Flow (3-scenario), Earnings Power Value, and Asset Valuation, with a quality scoring overlay. A stock needs 2/3 valuation methods to agree and a quality score ≥ 3.5/5 for a BUY rating.

Learn how this framework works →

This is a personal analysis tool, not financial advice. Do your own research before making investment decisions.